Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.9%

18 terminated/withdrawn out of 151 trials

Success Rate

86.4%

-0.2% vs industry average

Late-Stage Pipeline

12%

18 trials in Phase 3/4

Results Transparency

63%

72 of 114 completed trials have results

Key Signals

7 recruiting72 with results15 terminated

Enrollment Performance

Analytics

Phase 2

42(35.6%)

Phase 1

40(33.9%)

N/A

16(13.6%)

Phase 3

14(11.9%)

Phase 4

4(3.4%)

Early Phase 1

2(1.7%)

118Total

Phase 2(42)

Phase 1(40)

N/A(16)

Phase 3(14)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (151)

Showing 20 of 151 trials

NCT03511118Recruiting

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Role: collaborator

NCT04464980Phase 2Active Not Recruiting

Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

Role: collaborator

NCT04278404Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Role: collaborator

NCT07438041Not ApplicableNot Yet Recruiting

Linking Youth to Pre-Exposure Prophylaxis (PrEP) Services

Role: collaborator

NCT07510048Phase 2Not Yet Recruiting

Combatting HIV Or Other STIs Early (CHOOSE)

Role: collaborator

NCT03603808Phase 2Completed

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Role: collaborator

NCT07631598Not ApplicableNot Yet Recruiting

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

Role: collaborator

NCT06769854Phase 4Not Yet Recruiting

Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children

Role: collaborator

NCT03407638Not ApplicableCompleted

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial

Role: collaborator

NCT03918850Phase 3Completed

Medication Treatment for Opioid Use Disorder in Expectant Mothers

Role: collaborator

NCT02799485Phase 2Completed

sEphB4-HSA in Treating Patients With Kaposi Sarcoma

Role: collaborator

NCT04139304Early Phase 1Recruiting

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Role: collaborator

NCT06494904Phase 3Recruiting

Standard Versus High Dose ED-Initiated Buprenorphine Induction

Role: collaborator

NCT05938465Phase 1Recruiting

Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)

Role: collaborator

NCT07475728Not Yet Recruiting

EMS-Initiated Buprenorphine

Role: collaborator

NCT06323824Phase 4Recruiting

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Role: collaborator

NCT03427736Recruiting

Anesthetics and Analgesics in Children

Role: collaborator

NCT06023459Phase 3Completed

Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)

Role: collaborator

NCT04921787Not ApplicableActive Not Recruiting

EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

Role: collaborator

NCT03866174Phase 2Completed

A Study of Psilocybin for Major Depressive Disorder (MDD)

Role: collaborator